ArticleJournal of Cancer2022

A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer.

Sejin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.